Pharmaceutical Microbiology is the branch of Microbiology, which involves the study of microorganisms associated with the manufacture of pharmaceuticals. e.g. controlling the number of microorganisms in a process environment, excluding microorganisms and microbial by-products like exotoxin and endotoxin from water and other starting materials, and ensures the sterile finished pharmaceutical product. Pharmaceutical microbiology includes the research and development of anti-infective agents, where the use of microorganisms to detect mutagenic and carcinogenic activity in prospective drugs, and in the manufacture of pharmaceutical products likes insulin and human growth hormone.
Microbiology contains numerous sub-divisions which include:
Pharmaceutical Biotechnology is simply defined as, the science that covers all the technologies required for the production, manufacturing, and registration of biological drugs.
It Includes:
Title : New approach to hyponatremia yields high prevalence and identification of natriuretic protein that causes renal salt wasting (RSW) and new syndrome of RSW in alzheimer’s disease
John K Maesaka, NYU Long Island School of Medicine, United States
Title : Synergism in the permeability of the blood Brain barrier between heavy metals and electromagnetic fields
Bartolome Ribas Ozonas, Royal National Academy of Pharmacy, Spain
Title : Chameleon nanocarriers for dynamic delivery of RNA Medicines
Ernst Wagner, Ludwig-Maximilians-Universitat Munich, Germany
Title : Mucoadhesive electrospun fibers in oral drug delivery
Luis Jesus Villarreal Gomez, Universidad Autonoma de Baja California, Mexico
Title : Human nanomedicine: Emphasizing results of nanomaterials in humans
Thomas J. Webster, Hebei University of Technology, China
Title : Qualitative and quantitative measures of drugs’ placenta permeability - A chromatographic and computational approach
Anna Weronika Sobanska, Medical University of Lodz, Poland
Title : Manufacturing outlook on cell and Gene and aseptic processing according the EU GMP Annex 1
Richard Denk, SKAN AG, Switzerland
Title : Multi-detection of pharmaceutical contamination in environment
Andreia Freitas, INIAV and REQUIMTE, Portugal
Title : New approaches to inhibit miRNAs in an atherosclerosis pre-clinical model
Noemi Rotllan Vila, IIB SANT PAU and CIBERDEM, Spain
Title : The role of non-antibiotic drugs on the development of antibiotic resistance
Mujde Eryilmaz, Ankara University, Turkey